Effect of pre-harvest spray of calcium nitrate, boric acid and zinc sulphate on storability of Nagpur mandarin (Citrus reticulata Blanco)

An investigation was carried out at Fruit Research Farm, Department of Fruit Science at College of Horticulture and Forestry, Jhalawar during 16 September, 2014 to 1 March, 2015 to study the individual effect of Pre-harvest spray of Calcium nitrate, Zinc sulphate and Boric acid as well as their interaction on Storability of Nagpur mandarin (Citrus reticulata Blanco) after fruit set stage. Among different pre-harvest treatments, T27 treatment (Ca 3.0% + B 0.6% + Zn 0.6%) treated fruits had the longest shelf-life of 15 days at ambient conditions with lowest PLW (9.27 %), decay per cent (15.23 %) and better organoleptic ratting (8.41/10) and higher retention of juice percent (39.12 %) till end of storage period

Scope of nanotechnology in ovarian cancer therapeutics

This review describes the use of polymer micelle nanotechnology based chemotherapies for ovarian cancer. While various chemotherapeutic agents can be utilized to improve the survival rate of patients with ovarian cancer, their distribution throughout the entire body results in high normal organ toxicity. Polymer micelle nanotechnology aims to improve the therapeutic efficacy of anti-cancer drugs while minimizing the side effects. Herein, different types of polymer micelle technology based nanotherapies such as PLGA, polymerosomes, acid cleavable, thermosensitive, pH sensitive, and cross-linked micelles are introduced and structural differences are explained. Additionally, production methods, stability, sustainability, drug incorporation and drug release profiles of various polymer micelle based nanoformulations are discussed. An important feature of polymer micelle nanotechnology is the small size (10-100 nm) of particles which improves circulation and enables superior accumulation of the therapeutic drugs at the tumor sites. This review provides a comprehensive evaluation of different types of polymer micelles and their implications in ovarian cancer therapeutics

Curcumin nanoformulations: a future nanomedicine for cancer

Curcumin, a natural diphenolic compound derived from turmeric Curcuma longa, has proven to be a modulator of intracellular signaling pathways that control cancer cell growth, inflammation, invasion, apoptosis and cell death, revealing its anticancer potential. In this review, we focus on the design and development of nanoparticles, self-assemblies, nanogels, liposomes and complex fabrication for sustained and efficient curcumin delivery. We also discuss the anticancer applications and clinical benefits of nanocurcumin formulations. Only a few novel multifunctional and composite nanosystem strategies offer simultaneous therapy as well as imaging characteristics. We also summarize the challenges to developing curcumin delivery platforms and up-to-date solutions for improving curcumin bioavailability and anticancer potential for therapy

Purification and properties of diaminopimelate decarboxylase of Micrococcus glutamicus

Diaminopimelate decarboxylase (EC 4.1.1.20) of Micrococcus glutamicus ATCC 13059 was purified to homogeneity. The enzyme had an apparent molecular weight of 191,000 as determined by gel filtration on Sephadex G-200. At protein concentrations of 20 and 10 μg per ml and in the absence of pyridoxal-5'-phosphate, it dissociated into a species of molecular weight 94,000. The polypeptide chain molecular weight as determined by sodium dodecyl sulphate Polyacrylamide gel electrophoresis was 100,000. The Km formeso diaminopimelate was 0.5 mM and that for pyridoxal-5'-phosphate was 0.6 μM. Sulphydryl groups and pyridoxal-5'-phosphate were essential for activity and stability. The enzyme was inhibited significantly by L-lysine and DL-aspartic β-semialdehyde

Aspartokinase of a lysine producing mutant of Micrococcus glutamicus

Aspartokinase from Micrococcus glutamicus AEC RN-13-6/1 [a homoserine requiring, S-(2-aminoethyl)-L-cysteine resistant, lysine producing strain] was purified 71 fold. The partially purified enzyme was inhibited by L-lysine. L-threonine, L-methionine, L-isoleucine, L-valine and L-phenylalanine activated the enzyme and reversed the inhibition by L-lysine. Aspartokinase activity was not derepressed by growth-limiting concentrations of L-threonine and/or L-methionine. It was not repressed by an excess of L-lysine (20 mM) and/or L-isoleucine (15.3 mM). The degree of activation or inhibition by amino acids was dependant on the composition of the growth medium. This observation is in contrast with the enzyme from the original (non-lysine-producing) strain which was inhibited by lysine or threonine and in a concerted manner by threonine plus lysine

Gambogic acid: A shining natural compound to nanomedicine for cancer therapeutics

The United State Food and Drug Administration has permitted number of therapeutic agents for cancer treatment. Most of them are expensive and have some degree of systemic toxicity which makes overbearing in clinical settings. Although advanced research continuously applied in cancer therapeutics, but drug resistance, metastasis, and recurrence remain unanswerable These accounts to an urgent clinical need to discover natural compounds with precisely safe and highly efficient for the cancer prevention and cancer therapy. Gambogic acid (GA) is the principle bioactive and caged xanthone component, a brownish gamboge resin secreted from the of Garcinia hanburyi tree. This molecule showed a spectrum of biological and clinical benefits against various cancers. In this review, we document distinct biological characteristics of GA as a novel anti-cancer agent. This review also delineates specific molecular mechanism(s) of GA that are involved in anti-cancer, anti-metastasis, anti-angiogenesis, and chemo-/radiation sensitizer activities. Furthermore, recent evidence, development, and implementation of various nanoformulations of gambogic acid (nanomedicine) have been described

Engineered Exosomes for the Multimodal Imaging Directed Photo-Immunotherapy of Colorectal Cancer

Background: Rio Grande Valley experience severe cancer health disparity. A novel therapeutic modality may serve as better therapeutic option. Nanohybrids endowed with multifunctionality, longer circulation time, large surface area have emerged as an active preference for cancer research. However, rising concern of nanomaterials toxicity and scalability issues has slowed their translation to clinics. Exosomes (Exo) are endogenous endocytic origin 40-100 nm vesicles found in various body fluids, which in comparison to synthetic nanoparticles, are biodegradable, highly biocompatible as well as immunocompatible in nature. Although bulk isolation of exosomes from human body fluids is still a problem and engineering of exosomes to harness its potential is still in infancy. Methods: The Exo were isolated from dairy milk using EDTA precipitation method, and superparamagnetic iron oxide nanoparticles (MNPs) were synthesized by ammonium hydroxide co-precipitation method. The Exo were sonicated (60 sec) with MNPs and near-infrared (NIR) light-absorbing dye indocyanine green (ICG) and then incubated overnight at 37 oC. The characterization of ICG@Exo-MNPs was done using several techniques. The targeting nature of ICG@Exo-MNPs was determined on colorectal cancer cells SW480 and SW680. The phototransduction and in-vitro photothermal therapy were performed using 1W, 808 nm NIR laser. Results: The ICG@Exo-MNPs nanohybrid found to have size around 100 nm with good dispersity. The coating of exosomes and magnetic field actuation increased the targeting efficacy of ICG@Exo-MNPs in colorectal cancer cells by 10% in SW40 and 30% in SW680. ICG@Exo-MNPs killed the SW480 cells to more than 80% within 2 min. of NIR light irradiation. Conclusions: This study shows enhanced photothermal therapeutic behavior of ICG@Exo-MNPs for near-infrared fluorescence imaging directing killing of colorectal cancer cells

Response of bio-regulators to yield and quality of Indian mustard (Brassica juncea L. Czernj. and Cosson) under different irrigation environments

A field study was conducted during rabi seasons of 2008 and 2009 to evaluated of productivity of Indian mustard (Brassica juncea L.) by foliar spray of bio-regulators under different irrigation environments. Amongst treatments, the application of sufficient irrigation water (four irrigations) recorded the highest number siliqua per plant, higher number of seeds per siliqua, 1000 seed weight and yields as compared to all other irrigation treatments. Results show that an increased in seed yield of 92.40 and 39.37 % under sufficient irrigation and limitedwater condition in 2008 and 93.34% and 40.31% in 2009, respectively over deficient irrigation conditions, foliar sprays of 100 ppm thioglycollic acid at initiation of branching were recorded highest yield attributes and yields. Similarly, 500 ppm of thiourea at initiation of branching and flowering stages also gave second best highest yield attributes and yields as compared to all other bio-regulators spray stages. However, bio-regulators sprays were not recorded any significant effect on oil and protein content. The results were concluded that economic feasibility to improve productivity of Indian mustard with four irrigations levels and sprays of 100 ppm thioglycollic acid and 500 ppm of thiourea at initiation of branching and flowering stages under hyper arid environment

Curcumin induces chemo/radio-sensitization in ovarian cancer cells and curcumin nanoparticles inhibit ovarian cancer cell growth

<p>Abstract</p> <p>Background</p> <p>Chemo/radio-resistance is a major obstacle in treating advanced ovarian cancer. The efficacy of current treatments may be improved by increasing the sensitivity of cancer cells to chemo/radiation therapies. Curcumin is a naturally occurring compound with anti-cancer activity in multiple cancers; however, its chemo/radio-sensitizing potential is not well studied in ovarian cancer. Herein, we demonstrate the effectiveness of a curcumin pre-treatment strategy for chemo/radio-sensitizing cisplatin resistant ovarian cancer cells. To improve the efficacy and specificity of curcumin induced chemo/radio sensitization, we developed a curcumin nanoparticle formulation conjugated with a monoclonal antibody specific for cancer cells.</p> <p>Methods</p> <p>Cisplatin resistant A2780CP ovarian cancer cells were pre-treated with curcumin followed by exposure to cisplatin or radiation and the effect on cell growth was determined by MTS and colony formation assays. The effect of curcumin pre-treatment on the expression of apoptosis related proteins and β-catenin was determined by Western blotting or Flow Cytometry. A luciferase reporter assay was used to determine the effect of curcumin on β-catenin transcription activity. The poly(lactic acid-<it>co</it>-glycolic acid) (PLGA) nanoparticle formulation of curcumin (Nano-CUR) was developed by a modified nano-precipitation method and physico-chemical characterization was performed by transmission electron microscopy and dynamic light scattering methods.</p> <p>Results</p> <p>Curcumin pre-treatment considerably reduced the dose of cisplatin and radiation required to inhibit the growth of cisplatin resistant ovarian cancer cells. During the 6 hr pre-treatment, curcumin down regulated the expression of Bcl-X_Land Mcl-1 pro-survival proteins. Curcumin pre-treatment followed by exposure to low doses of cisplatin increased apoptosis as indicated by annexin V staining and cleavage of caspase 9 and PARP. Additionally, curcumin pre-treatment lowered β-catenin expression and transcriptional activity. Nano-CUR was successfully generated and physico-chemical characterization of Nano-CUR indicated an average particle size of ~70 nm, steady and prolonged release of curcumin, antibody conjugation capability and effective inhibition of ovarian cancer cell growth.</p> <p>Conclusion</p> <p>Curcumin pre-treatment enhances chemo/radio-sensitization in A2780CP ovarian cancer cells through multiple molecular mechanisms. Therefore, curcumin pre-treatment may effectively improve ovarian cancer therapeutics. A targeted PLGA nanoparticle formulation of curcumin is feasible and may improve the <it>in vivo </it>therapeutic efficacy of curcumin.</p